OP0115 EFFICACY AND SAFETY OF ABBV-3373, A NOVEL ANTI-TNF GLUCOCORTICOID RECEPTOR MODULATOR ANTIBODY DRUG CONJUGATE, IN PATIENTS WITH MODERATE TO SEVERE RHEUMATOID ARTHRITIS DESPITE METHOTREXATE THERAPY: A PHASE 2A PROOF OF CONCEPT STUDY
Frank Buttgereit, Jacob Aelion, Bernadette Rojkovich, Anna Zubrzycka‐Sienkiewicz, Timothy R. D. J. Radstake, S. Chen, Dilek Arikan, H. Küpper, Howard Amital
Topics & Concepts
MedicineRheumatoid arthritisInternal medicineClinical endpointAdalimumabPlaceboMethotrexateClinical trialPathologyAlternative medicineMonoclonal and Polyclonal Antibodies ResearchSystemic Lupus Erythematosus ResearchBiosimilars and Bioanalytical Methods